126 related articles for article (PubMed ID: 33723143)
21. Dosimetric comparison between realistic ocular model and other models for COMS plaque brachytherapy with
Ebrahimi-Khankook A; Vejdani-Noghreiyan A
Radiat Environ Biophys; 2018 Aug; 57(3):265-275. PubMed ID: 29882078
[TBL] [Abstract][Full Text] [Related]
22. Conservative treatment of retinoblastoma. The use of plaque brachytherapy.
Hernandez JC; Brady LW; Shields CL; Shields JA; DePotter P
Am J Clin Oncol; 1993 Oct; 16(5):397-401. PubMed ID: 8213621
[TBL] [Abstract][Full Text] [Related]
23. Plaque radiotherapy in the management of retinoblastoma.
Kiratli H; Bilgiç S; Atahan IL
Turk J Pediatr; 1998; 40(3):393-7. PubMed ID: 9763903
[TBL] [Abstract][Full Text] [Related]
24. [Available approaches to retinoblastoma therapy--literature review].
Morawski K; Kulig-Stochmal A; Drychowska-Jęmhorska JJ; Kuhicka-Trząska A; Romanowska-Dixon B
Klin Oczna; 2015; 117(1):45-9. PubMed ID: 26349159
[TBL] [Abstract][Full Text] [Related]
25. AAPM TG-43U1 formalism adaptation and monte carlo dosimetry simulations of multiple-radionuclide brachytherapy sources.
Nuttens VE; Lucas S
Med Phys; 2006 Apr; 33(4):1101-7. PubMed ID: 16696487
[TBL] [Abstract][Full Text] [Related]
26. Assessment of combined modality therapy for non-small-cell lung carcinoma: A simulation study concerning concurrent chemo-brachytherapy.
Rezaei H; Mostaghimi H; Mehdizadeh AR
J Cancer Res Ther; 2022; 18(4):946-952. PubMed ID: 36149145
[TBL] [Abstract][Full Text] [Related]
27. Calculated microdosimetric characteristics of 125I and 103Pd brachytherapy seeds at different depths in water.
Wuu CS; Chen J
Radiat Prot Dosimetry; 2006; 122(1-4):506-8. PubMed ID: 17189276
[TBL] [Abstract][Full Text] [Related]
28. Dosimetric parameters of the new design (103)Pd brachytherapy source based on Monte Carlo study.
Saidi P; Sadeghi M; Shirazi A; Tenreiro C
Phys Med; 2012 Jan; 28(1):13-8. PubMed ID: 21251862
[TBL] [Abstract][Full Text] [Related]
29. A Monte Carlo evaluation of dose enhancement by cisplatin and titanocene dichloride chemotherapy drugs in brachytherapy with photon emitting sources.
Yahya Abadi A; Ghorbani M; Mowlavi AA; Knaup C
Australas Phys Eng Sci Med; 2014 Jun; 37(2):327-36. PubMed ID: 24706342
[TBL] [Abstract][Full Text] [Related]
30. Monte Carlo dosimetry of the eye plaque design used at the St. Erik Eye Hospital for (125)I brachytherapy.
Karlsson M; Nilsson J; Lundell M; Carlsson Tedgren A
Brachytherapy; 2014; 13(6):651-6. PubMed ID: 24950821
[TBL] [Abstract][Full Text] [Related]
31. Improved treatment planning for COMS eye plaques.
Astrahan MA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1227-42. PubMed ID: 15752905
[TBL] [Abstract][Full Text] [Related]
32. Monte Carlo simulation of tilted contact plaque brachytherapy placement for juxtapapillary retinoblastoma.
Nakamura S; Murakami N; Suzuki S; Ito K; Takemori M; Nakayama H; Kaga K; Chiba T; Iijima K; Takahashi K; Goka T; Itami J; Okamoto H; Igaki H
Radiat Oncol; 2022 Jan; 17(1):16. PubMed ID: 35073956
[TBL] [Abstract][Full Text] [Related]
33. COMS eye plaque brachytherapy dosimetry simulations for 103Pd, 125I, and 131Cs.
Melhus CS; Rivard MJ
Med Phys; 2008 Jul; 35(7):3364-71. PubMed ID: 18697560
[TBL] [Abstract][Full Text] [Related]
34. Treatment of Retinoblastoma in 2015: Agreement and Disagreement.
Abramson DH; Shields CL; Munier FL; Chantada GL
JAMA Ophthalmol; 2015 Nov; 133(11):1341-7. PubMed ID: 26378747
[TBL] [Abstract][Full Text] [Related]
35. Effect of improved TLD dosimetry on the determination of dose rate constants for (125)I and (103)Pd brachytherapy seeds.
Rodriguez M; Rogers DW
Med Phys; 2014 Nov; 41(11):114301. PubMed ID: 25370677
[TBL] [Abstract][Full Text] [Related]
36. HAND-HELD OPTICAL COHERENCE TOMOGRAPHY MONITORING OF CHEMORESISTANT RETINOBLASTOMA.
Malik K; Welch RJ; Shields CL
Retin Cases Brief Rep; 2020; 14(4):368-371. PubMed ID: 29443806
[TBL] [Abstract][Full Text] [Related]
37. Comparison of radiation dosimetry in water and in solid phantom materials for I-125 and Pd-103 brachytherapy sources: EGS4 Monte Carlo study [Med. Phys. 21, 631-641 (1994)].
Luxton G
Med Phys; 1994 Dec; 21(12):1989-90. PubMed ID: 7700208
[No Abstract] [Full Text] [Related]
38. Thermoluminescent and Monte Carlo dosimetry of IR06-103Pd brachytherapy source.
Saidi P; Sadeghi M; Hosseini SH; Tenreiro C
J Appl Clin Med Phys; 2011 Nov; 12(4):3581. PubMed ID: 22089014
[TBL] [Abstract][Full Text] [Related]
39. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
[TBL] [Abstract][Full Text] [Related]
40. Determination of the intrinsic energy dependence of LiF:Mg,Ti thermoluminescent dosimeters for 125I and 103Pd brachytherapy sources relative to 60Co.
Reed JL; Rasmussen BE; Davis SD; Micka JA; Culberson WS; DeWerd LA
Med Phys; 2014 Dec; 41(12):122103. PubMed ID: 25471976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
